Effect of T-1815, a new colonic prokinetic compound, on gastrointestinal motility was studied in anesthetized and conscious dogs fasted for 24 hr before experiment.
Introduction
T-1815 is a new colonic prokinetic compound which reverses the delay of colonic propulsion induced by clonidine and loperamide in mice and rats, and causes neither diarrhea nor tolerance (Yamada and Onoda, 1992; Yamada and Onoda, 1993) . It was of interest to clarify mechanisms of the action of the compound on the motility of the gastrointestinal tract, especially of the colon, which might be involved in its strong colonic propulsive activity. In the present study, effects of T-1815 on the gastrointestinal motility was studied in anesthetized and conscious dogs.
Methods

Anesthetized dogs
Five (4 male and 1 female) adult dogs, weighing 11-13 kg, were used. After fasting for 24 hr, the animals were anesthetized with 30 mg/kg, i.v. pentobarbital sodium, the abdominal cavity was opened and strain gauge force transducer (F-12IS, Star Medical Inc.) each was sutured on the serosal surface of the gastric body (10-15 cm proximal to the pylorus), gastric antrum (3-5 cm to the pylorus), duodenum (10-15 cm distal to the pylorus), jejunum (midportion of the small intestine), proximal colon (ascending, 5-7 cm distal to the ileo-cecal junction) and distal colon (descending, 15-20 
Conscious dogs
Seven (5 male and 2 female) adult dogs, weighing 18-20 kg, were used.
Implantation of the strain gauge force transducers (F-12IS, Star Medical Inc.) was made under pentobarbital anesthesia (30 mg/kg, i.v.). In 5 animals, the transducers were sutured on the serosal surface of the gastric antrum (3-5 cm proximal to the pylorus), duodenum (10-15 cm distal to the pylorus) and middle (transverse) colon. In the other 2 dogs, the transducers were sutured on the proximal (ascending), middle (transverse) and distal (descending) site of the colon. At the beginning of the experiment, the lead wires of the transducers were connected to strain amplifiers (8M-52, NEC-San'ei). Contractile activity of the circular smooth muscle was recorded on a Linearcorder (WR-3701, Graphtec), and also on a data recorder (DFR-3315, Sony Magnescale) in order to replay them later. On days without an experiment, the animals were fed once a day in the morning. They usually had the habit of defecation in their cages within 2 hr after feeding. Experiments were started about 2 weeks after the surgery and the animals were fasted for about 24 hr before experiment so that they were in the interdigestive state (Yamada et al., 1982) . Recording was continued for 6-10 hrs on the day of experiment, and repeated at intervals of 5 days or more in each animal.
Other details were described previously (Yamada et al., 1982 ; Yamada et al., 1983) . ly occurring contractions at all sites of the gastrointestinal tract recorded in anesthetized dogs ( Fig. 1-a) . However, T-1815 at intravenous doses of 0.3-3.0 mg/kg caused divergent motility effects between the stomach and intestine. In the gastric body and antrum, T-1815 caused both a slight decrease in amplitude and a fall in tone followed by a slight increase in amplitude of the spontaneous contractions ( Fig. 1, 2 ). In the small and large intestine, T-1815 caused only a potentiating effect (an increase in amplitude and/or in tone of the contractions, Fig. 1 and 2). However, T-1815 at the i.v. doses of 0.3 to 3 mg/kg caused only small, but biphasic effects on the AUC in the gastric body and antrum.
In the duodenum and jejunum, however, T-1815 produced a dose-dependent increase in AUC. The dose of 3 mg/kg T-1815 produced clearly larger AUC values of contractions than 0.01 mg/kg bethanechol.
In the colon, T-1815 at 1 and 3 mg/kg, i.v. elicited abrupt increases in colonic contractions (high-amplitude contractions) with latencies of 3.9 to 20.9 min after the administration (Fig. 1, 2) . The colonic high-amplitude contractions were observed in 2 out of 5 animals tested at the dose of 1 mg/kg, i.v., and 4 out of 5 at 3 mg/kg, i.v. (Table 2 ). The high-amplitude contractions in the distal colon were recorded with a time lag of 13 to 22 sec following those in the proximal colon.
Conscious dogs i) Intravenous administration of T-1815
T-1815 was administered intravenously to conscious dogs 20-30 min after cessation of the interdigestive phase III contractions at the stomach. There were no clear responses to the compound at 1 mg/kg in 3 out of 4 animals ( Fig. 3-A) , although one animal showed contractions similar to the interdigestive phase III contractions in the stomach and duodenum. At 3 mg/kg, the phase III-like contractions followed by persistent contractions with relatively low amplitudes were observed in one out of 3 animals ( Fig. 3-B) . In the colon, T-1815 at 3 mg/kg caused a slight depression of the motility in 2 out of 3 animals ( Fig. 3-B) .
ii) Oral administration of T-1815
Effect of oral administration of T-1815 during the phase I of the interdigestive state was examined at doses of 30 mg/kg (N=2) and 50 mg/kg (N=2). These dosages caused persistent contractions in 1 out of 2 experiments at the stomach and duodenum (Fig. 4) . In the middle colon, the high-amplitude contractions were recorded at the doses of 30 (N=1) and 50 (N=1) mg/kg of T-1815 (Fig. 4-d , Table 3 -A).
In order to ascertain where the high-amplitude contractions occur, experiments were performed with two dogs in which transducers were implanted on the proximal, middle and distal sites of the colon. The high-amplitude contractions were observed at the proximal colon in all of the three experiments after oral administration of T-1815 at 10 and 30 mg/kg (Fig. 5, Table 3 -B). The contractions migrated to the middle colon in only one experiment. In addition, there were no high-amplitude contractions recorded in the distal colon.
No defecations were observed during the experiments with conscious animals. Moreover, no high-amplitude contractions were recorded in the animals during the control experiment (Table 3) .
Discussion
In anesthetized dogs, T-1815 caused a potentiating effect on the spontaneous contractions of the small and large intestine, although the compound showed a biphasic effect (a slight decrease followed by an increase) on the contractions of the stomach. In addition, T-1815 at 1 and 3 mg/kg, i.v. produced high-amplitude contractions in the colon. The cholinergic agonist bethanechol never caused high-amplitude contractions in the colon though it produced only contractile responses in all of the sites examined. Thus, the pharmacological property of T-1815 is probably different from that of cholinergic agonists. Karaus and Sarna (1987) have found that, in conscious dogs, the high-amplitude contractions which migrate to the distal colon precede the spontaneous and chemically induced defecation, and they called these contractions 'giant migrating contractions'. A similarly unique motility of the colon was also observed in humans by Narducci et al. (1987) and MorenoOsset et al. (1989) . The latter authors demonstrated that the high-amplitude contractions propel the bolus caudad in the colon.
Development of the colonic high-amplitude contractions induced by intravenous T-1815 in anesthetized dogs had a time lag of 13 to 22 sec between the proximal and distal site, suggesting that the contractions migrate caudad.
In conscious dogs, intravenous T-1815 at 1 and 3 mg/kg caused no clear effects on the motility of the gastric antrum, duodenum and colon in the majority of the animals examined.
T-1815 developed contractions similar to the interdigestive phase III contractions in only 2 animals out of 7, and did not cause such a clear depression of the contractions in the stomach and such a conspicuous occurrence of high-amplitude contractions in the colon as observed in anesthetized dogs.
The reason why the intravenous T-1815 did not cause high-amplitude contractions in conscious dogs at the same doses as in anesthetized animals is unclear, but some explanations are possible. First, the animals used in the present study were fasted for 24 hr before experiment, and they usually finished defecation within 2 hr after feeding. Therefore, contents (feces) in the colon to be propelled caudad might be scarce during the experiment.
It may be difficult to cause defecation under such conditions even if T-1815 had a strong colonic propulsive activity. Some reflex activities which exist in conscious animals may play a role not to cause extraordinal defecation. Second, T-1815 has a unique property that, in mice, it causes a remarkable prokinetic effect when colonic propulsion is disturbed (delayed) by chemical agents,
despite it induces only a weak effect in naive (untreated) animals (Yamada and Onoda, 1993) .
Since pentobarbital inhibits the gastric emptying and small intestinal transit (Borella and Lippmann, 1980) , the anesthetic will possibly delay the colonic propulsion. It, therefore, is suggested that, under such an anesthetic condition, T-1815 can cause the high-amplitude contractions which is known to play an important role to cause defecation (Karaus and Sarna, 1987) .
One of the two animals in which the transducer was implanted on only the midportion of the colon showed development of the high-amplitude contractions after oral administration of 30 mg/kg T-1815. While, in all of the 3 experiments using dogs with transducers implanted on the three sites of the colon, i.e., the proximal, middle and distal colon, T-1815 at relatively low oral doses (10 and 30 mg/kg) produced high-amplitude contractions at the proximal site, and the contractions at the middle colon were observed in only one experiment. Furtheremore, there were no high-amplitude contractions in the distal colon. Therefore, T-1815 appears to have a characteristic to cause high-amplitude contractions in the proximal site of the colon rather than in the distal sites, and it may not cause the contractions to migrate to the distal site by the reason mentioned above. Sarna et al. (1987) have also reported that, in conscious dogs, such high-amplitude (giant) contractions can easily occur at the proximal region of the colon, and the majority of the proximally originated contractions migrate caudad before defecation.
In the present study, there were no defecation in conscious dogs despite that the highamplitude contractions occurred. This is probably due to the emptied colon after defecation and 24-hr fasting.
Further studies are necessary to define the effect of T-1815 on the gastrointestinal motility during the digestive state or under disturbed colonic propulsion.
